IRF7 Antikörper (C-Term)
Kurzübersicht für IRF7 Antikörper (C-Term) (ABIN2475148)
Target
Alle IRF7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Maus, Ratte (Rattus)
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Immunogen
- 14 amino acid peptide sequence near the carboxy terminus of human IRF7.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling." in: The Journal of biological chemistry, Vol. 280, Issue 13, pp. 12262-70, (2005) (PubMed).
: "
-
Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling." in: The Journal of biological chemistry, Vol. 280, Issue 13, pp. 12262-70, (2005) (PubMed).
-
- IRF7 (Interferon Regulatory Factor 7 (IRF7))
-
Andere Bezeichnung
- IRF7
-
Hintergrund
- Synonyms: INTERFERON REGULATORY FACTOR 7
-
Gen-ID
- 3665
-
UniProt
- Q92985
-
Pathways
- TLR Signalweg, Activation of Innate immune Response, Hepatitis C, Toll-Like Receptors Cascades, Autophagie
Target
-